Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
Teva
Deloitte
McKesson
Johnson and Johnson
Farmers Insurance
Cipla
Dow
Chubb
Harvard Business School

Generated: January 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017607

« Back to Dashboard

NDA 017607 describes DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, which is a drug marketed by Abbott, B Braun, Icu Medical Inc, and Miles, and is included in five NDAs. It is available from two suppliers. Additional details are available on the DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER profile page.

The generic ingredient in DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER is dextrose; sodium chloride. There are eight drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the dextrose; sodium chloride profile page.
Summary for 017607
Tradename:DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
Applicant:Icu Medical Inc
Ingredient:dextrose; sodium chloride
Patents:0
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 017607
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER dextrose; sodium chloride INJECTABLE;INJECTION 017607 NDA Hospira, Inc. 0409-7926 0409-7926-09 12 POUCH in 1 CASE (0409-7926-09) > 1 BAG in 1 POUCH > 1000 mL in 1 BAG
DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER dextrose; sodium chloride INJECTABLE;INJECTION 017607 NDA Hospira, Inc. 0409-7926 0409-7926-03 24 POUCH in 1 CASE (0409-7926-03) > 1 BAG in 1 POUCH > 500 mL in 1 BAG

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength5GM/100ML;450MG/100ML
Approval Date:Approved Prior to Jan 1, 1982TE:APRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
Fish and Richardson
Novartis
Deloitte
US Department of Justice
Daiichi Sankyo
Johnson and Johnson
Chubb
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot